Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Jit

Showing results (231-240 of 388) with videos related to

Pageof 39
Sort By:
Plos One|June 17, 2014
Nosocomial transmission of C. difficile in English hospitals from patients with symptomatic infectionEsther van Kleef, Antonio Gasparrini, Rebecca Guy, et al.
Cost Effectiveness and Resource Allocation : C/E|May 14, 2024
An overview of the perspectives used in health economic evaluationsManit Sittimart, Waranya Rattanavipapong, Andrew J Mirelman, et al.
Vaccine|August 19, 2014
Comparing the cost-effectiveness of two- and three-dose schedules of human papillomavirus vaccination: a transmission-dynamic modelling studyJean-François Laprise, Mélanie Drolet, Marie-Claude Boily, et al.
BMC Medicine|March 3, 2021
Effectiveness and cost-effectiveness of eliminating cervical cancer through a tailored optimal pathway: a modeling studyChangfa Xia, Xiaoqian Xu, Xuelian Zhao, et al.
The Lancet. Global Health|July 21, 2020
Routine childhood immunisation during the COVID-19 pandemic in Africa: a benefit-risk analysis of health benefits versus excess risk of SARS-CoV-2 infectionKaja Abbas, Simon R Procter, Kevin van Zandvoort, et al.
Pharmacoeconomics - Open|October 20, 2025
An Introduction to Costing and the Types of Costs Used within Health Economic StudiesHugo C Turner, Juan Carlos Rivillas-Garcia, Shankar Prinja, et al.
Health Research Policy and Systems|June 26, 2024
A health technology assessment of COVID-19 vaccination for Nigerian decision-makers: Identifying stakeholders and pathways to support evidence uptakeBenjamin S C Uzochukwu, Chinyere Okeke, Faisal Shuaib, et al.
Sexually Transmitted Diseases|February 15, 2011
Prevalence of human papillomavirus antibodies in males and females in EnglandSarika Desai, Ruth Chapman, Mark Jit, et al.
Vaccine|March 17, 2023
Challenges and opportunities in developing a Shigella-containing combination vaccine for children in low- and middle-income countries: Report of an expert conveningMark S Riddle, A Louis Bourgeois, Allison Clifford, et al.
International Journal of Cancer|February 27, 2016
Eurogin Roadmap 2015: How has HPV knowledge changed our practice: VaccinesJulia M L Brotherton, Mark Jit, Patti E Gravitt, et al.
Pageof 39

Showing results (231-240 of 388) with videos related to

Sort By:
Pageof 39
Plos One|June 17, 2014
Nosocomial transmission of C. difficile in English hospitals from patients with symptomatic infectionEsther van Kleef, Antonio Gasparrini, Rebecca Guy, et al.
Cost Effectiveness and Resource Allocation : C/E|May 14, 2024
An overview of the perspectives used in health economic evaluationsManit Sittimart, Waranya Rattanavipapong, Andrew J Mirelman, et al.
Vaccine|August 19, 2014
Comparing the cost-effectiveness of two- and three-dose schedules of human papillomavirus vaccination: a transmission-dynamic modelling studyJean-François Laprise, Mélanie Drolet, Marie-Claude Boily, et al.
BMC Medicine|March 3, 2021
Effectiveness and cost-effectiveness of eliminating cervical cancer through a tailored optimal pathway: a modeling studyChangfa Xia, Xiaoqian Xu, Xuelian Zhao, et al.
The Lancet. Global Health|July 21, 2020
Routine childhood immunisation during the COVID-19 pandemic in Africa: a benefit-risk analysis of health benefits versus excess risk of SARS-CoV-2 infectionKaja Abbas, Simon R Procter, Kevin van Zandvoort, et al.
Pharmacoeconomics - Open|October 20, 2025
An Introduction to Costing and the Types of Costs Used within Health Economic StudiesHugo C Turner, Juan Carlos Rivillas-Garcia, Shankar Prinja, et al.
Health Research Policy and Systems|June 26, 2024
A health technology assessment of COVID-19 vaccination for Nigerian decision-makers: Identifying stakeholders and pathways to support evidence uptakeBenjamin S C Uzochukwu, Chinyere Okeke, Faisal Shuaib, et al.
Sexually Transmitted Diseases|February 15, 2011
Prevalence of human papillomavirus antibodies in males and females in EnglandSarika Desai, Ruth Chapman, Mark Jit, et al.
Vaccine|March 17, 2023
Challenges and opportunities in developing a Shigella-containing combination vaccine for children in low- and middle-income countries: Report of an expert conveningMark S Riddle, A Louis Bourgeois, Allison Clifford, et al.
International Journal of Cancer|February 27, 2016
Eurogin Roadmap 2015: How has HPV knowledge changed our practice: VaccinesJulia M L Brotherton, Mark Jit, Patti E Gravitt, et al.
Pageof 39